Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
16.46
0.25 (1.54%)
At close: Oct 15, 2025, 3:59 PM
16.45
-0.06%
After-hours: Oct 15, 2025, 06:21 PM EDT
Tekla Life Sciences Investors Ratios and Metrics
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
PE Ratio | 4.96 | 15.78 | -3.35 | 7.82 |
Forward PE Ratio | n/a | n/a | n/a | n/a |
PEG Ratio | 0.02 | -0.13 | 0.01 | -0.16 |
PS Ratio | 4.88 | 8.96 | 11.01 | 11.21 |
PB Ratio | 0.92 | 0.88 | 0.88 | 0.96 |
P/FCF Ratio | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a |
Price to Fair Value | 0.92 | 0.88 | 0.88 | 0.96 |
Debt / Equity Ratio | n/a | n/a | 0.03 | 0.00 |
Debt to Assets Ratio | n/a | n/a | 0.03 | 0.00 |
Debt to Capital Ratio | n/a | n/a | 0.03 | 0.00 |
LT Debt to Capital Ratio | n/a | n/a | n/a | n/a |
Debt to Market Cap | n/a | n/a | 0.03 | 0.02 |
Quick Ratio | 0.32 | n/a | 0.12 | 0.01 |
Current Ratio | 0.32 | n/a | 0.12 | 0.01 |
Cash Ratio | n/a | n/a | 0.00 | 0.00 |
Solvency Ratio | 98.15 | 74.89 | -6.04 | 6.39 |
Asset Turnover | 0.19 | 0.10 | 0.08 | 0.08 |
Receivables Turnover | 375.09 | 7.81 | 51.10 | 299.48 |
Payables Turnover | n/a | n/a | 1.09 | 40.42 |
Inventory Turnover | n/a | 0.26 | n/a | n/a |
Fixed Asset Turnover | n/a | n/a | n/a | n/a |
Working Capital Turnover | 39.06 | 138.36 | -4.23 | -8.11 |
Financial Leverage Ratio | 1.00 | 1.00 | 1.04 | 1.02 |
Interest Coverage | n/a | n/a | n/a | n/a |
Debt Service Coverage | n/a | n/a | -9.43 | 6.43 |
Return on Equity | 0.19 | 0.06 | -0.26 | 0.12 |
Return on Assets | 0.19 | 0.06 | -0.25 | 0.12 |
Return on Invested Capital | 0.18 | -0.01 | -0.25 | 0.12 |
OCF Ratio | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a |
FCF/OCF Ratio | n/a | n/a | n/a | n/a |
ST OCF Coverage | n/a | n/a | n/a | n/a |
OCF Coverage Ratio | n/a | n/a | n/a | n/a |
CapEx Coverage Ratio | n/a | n/a | n/a | n/a |
Dividend & CapEx Coverage | n/a | n/a | n/a | n/a |
Dividend Yield | 0.11 | 0.10 | 0.11 | 0.08 |
Dividend Yield % | 11.01 | 10.26 | 10.76 | 8.12 |
Payout Ratio | 0.55 | 1.62 | -0.36 | 0.64 |
Dividend Per Share | 1.66 | 1.28 | 1.47 | 1.69 |
Gross Profit Margin | 1.00 | 0.46 | 0.83 | 0.87 |
EBIT Margin | 0.98 | 0.57 | -3.28 | 1.43 |
EBITDA Margin | 0.98 | 0.57 | -3.28 | 1.43 |
Operating Profit Margin | 0.98 | -0.13 | -3.28 | 1.43 |
Pretax Profit Margin | 0.98 | 0.57 | -3.28 | 1.43 |
Continuous Operations Margin | 0.98 | 0.57 | -3.28 | 1.43 |
Net Profit Margin | 0.98 | 0.57 | -3.28 | 1.43 |
Bottom Line Profit Margin | 0.98 | 0.57 | -3.28 | 1.43 |
FCF Margin | n/a | n/a | n/a | n/a |
Revenue Per Share | 3.09 | 1.39 | 1.24 | 1.86 |
Net Income Per Share | 3.04 | 0.79 | -4.07 | 2.66 |
Interest Debt Per Share | n/a | n/a | 0.43 | 0.06 |
Cash Per Share | 0.61 | 0.54 | 1.28 | 0.71 |
Book Value Per Share | 16.38 | 14.21 | 15.49 | 21.58 |
Tangible Book Value Per Share | 16.38 | 14.21 | 15.49 | 21.58 |
Shareholders' Equity Per Share | 16.38 | 14.21 | 15.49 | 21.58 |
Operating Cash Flow Per Share | n/a | n/a | n/a | n/a |
CapEx Per Share | n/a | n/a | n/a | n/a |
Free Cash Flow Per Share | n/a | n/a | n/a | n/a |
Net Income / EBT | 1.00 | 1.00 | 1.00 | 1.00 |
EBT / EBIT | 1.00 | -4.26 | 1.00 | 1.00 |
Effective Tax Rate | n/a | n/a | n/a | n/a |
EV Multiple | 4.96 | 15.78 | -3.46 | 7.84 |
Source: Financial Modeling Prep. Financial Sources.